Form 4: Adena Friedman Sells NDAQ Stock Under 10b5-1 Plan

Adena Friedman, Chair and CEO of NASDAQ, Inc., has reported transactions involving the sale of common stock and the acquisition of restricted stock units under a Rule 10b5-1 trading plan.

Summary

• Adena Friedman, Chair and CEO of NASDAQ, Inc., executed a series of transactions on April 1, 2026.
• She sold 113,611 shares of common stock at a weighted average price of $85.44, with individual sales ranging from $85.00 to $85.88.
• These sales were conducted under a Rule 10b5-1(c) trading plan adopted on September 11, 2025.
• Friedman also acquired 39,929 Restricted Stock Units (RSUs) with a reported value of $0.
• These RSUs are set to vest in stages: 33% on April 1, 2028, 33% on April 1, 2029, and the remainder on April 1, 2030.
• Additionally, 13,739 shares were withheld for taxes in connection with the settlement of an equity award.
• Following these transactions, Friedman beneficially owns 2,005,680 shares of common stock directly, and 73,500 shares indirectly through two irrevocable trusts.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. While the sale of shares by the CEO could be a negative signal, the execution under a Rule 10b5-1 plan mitigates insider trading concerns, and the acquisition of RSUs indicates continued long-term incentive alignment.

Positives

• Acquisition of 39,929 Restricted Stock Units (RSUs) indicates continued equity-based compensation and alignment with long-term company performance.
• The RSUs have a structured vesting schedule (2028-2030), suggesting a commitment to long-term employee retention.
• The transactions were executed under a Rule 10b5-1(c) trading plan, which is designed to prevent insider trading concerns by pre-arranging trades.
• Friedman retains a significant beneficial ownership of 2,005,680 shares directly and 73,500 indirectly, demonstrating substantial continued investment in the company.

Negatives

• Sale of 113,611 shares of common stock by the CEO, even under a 10b5-1 plan, could be perceived negatively by the market.
• The weighted average sale price of $85.44 is noted, with a range of $85.00 to $85.88, indicating a significant value of shares disposed of.

Risks

• Potential for negative market perception due to the CEO's sale of a substantial number of shares, despite being under a pre-arranged plan.
• The vesting schedule of the RSUs implies that a portion of the CEO's compensation is tied to future performance, which carries inherent performance-related risks.

Future Outlook

The filing indicates future vesting of Restricted Stock Units (RSUs) for Adena Friedman, with tranches vesting on April 1, 2028, April 1, 2029, and April 1, 2030. An employee stock option is exercisable and vests on January 3, 2027, expiring January 3, 2032.

Management Comments

• The reported sale was effected pursuant to a Rule 10b5-1(c) trading plan adopted on September 11, 2025.
• The reporting person undertakes to provide to the Issuer, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Industry Context

StockSavvy.ai notes that the sale of shares by a CEO, even under a 10b5-1 plan, is a common event in the financial services and technology sectors. Such plans are standard practice for executives to diversify holdings or meet financial obligations while adhering to insider trading regulations. The acquisition of RSUs is also typical for aligning executive compensation with long-term company performance and shareholder value.

Stakeholder Impact

• Shareholders: The sale of shares by the CEO, though under a plan, may lead to short-term market scrutiny. However, the continued substantial ownership and RSU grants suggest ongoing commitment.
• Employees: The RSU grants reinforce the company's strategy of using equity to incentivize and retain key personnel.
• Management: The transactions reflect standard executive compensation and portfolio management practices.

Next Steps

• Vesting of 33% of RSUs on April 1, 2028.
• Vesting of 33% of RSUs on April 1, 2029.
• Vesting of remaining RSUs on April 1, 2030.
• Option exercisable from January 3, 2027, expiring January 3, 2032.

Key Dates

Recommendation

The filing details routine insider transactions under a pre-arranged plan, including stock sales and RSU grants. While the sale of shares by the CEO warrants attention, the adherence to a 10b5-1 plan and the continued significant beneficial ownership suggest no immediate change in fundamental outlook. The RSU grants indicate ongoing long-term incentive alignment. Therefore, a 'hold' recommendation is appropriate pending further fundamental developments.

Keywords

NASDAQ, Adena Friedman, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Restricted Stock Units, RSUs, Beneficial Ownership, Equity Award, SEC Filing